{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:22:25Z","timestamp":1761157345341,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10067-022-06170-7","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T21:02:51Z","timestamp":1649970171000},"page":"2439-2448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical significance of anti-transcriptional intermediary factor 1-\u03b3 antibody in patients with dermatomyositis: a monocentric cross-sectional study"],"prefix":"10.1007","volume":"41","author":[{"given":"Huanhuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-4197","authenticated-orcid":false,"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"6170_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00403-016-1704-1","volume":"309","author":"G Merlo","year":"2017","unstructured":"Merlo G, Clapasson A, Cozzani E, Sanna L, Pesce G, Bagnasco M et al (2017) Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets. Arch Dermatol Res 309:87\u201395","journal-title":"Arch Dermatol Res"},{"issue":"335","key":"6170_CR2","first-page":"9","volume":"120","author":"H Kankeleit","year":"1916","unstructured":"Kankeleit H (1916) \u00dcber primaire nichteitrige polymyositis. Dtsch Arch Klin Med 120(335):9","journal-title":"Dtsch Arch Klin Med"},{"key":"6170_CR3","first-page":"489","volume":"53","author":"G Stertz","year":"1916","unstructured":"Stertz G (1916) Polymyositis. Berl Klin Wochenschau 53:489","journal-title":"Berl Klin Wochenschau"},{"key":"6170_CR4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fimmu.2017.00992","volume":"8","author":"A Aussy","year":"2017","unstructured":"Aussy A, Boyer O, Cordel N (2017) Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer. Front Immunol 8:992","journal-title":"Front Immunol"},{"key":"6170_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1203475416665601","volume":"21","author":"JK Qiang","year":"2017","unstructured":"Qiang JK, Kim WB, Baibergenova A, Alhusayen R (2017) Risk of malignancy in dermatomyositis and polymyositis. J Cutan Med Surg 21:131\u2013136","journal-title":"J Cutan Med Surg"},{"key":"6170_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/rheumatology\/kez572","volume":"59","author":"J De Vooght","year":"2020","unstructured":"De Vooght J, Vulsteke JB, De Haes P, Bossuyt X, Lories R, De Langhe E (2020) Anti-TIF1-gamma autoantibodies: warning lights of a tumour autoantigen. Rheumatology (Oxford) 59:469\u2013477","journal-title":"Rheumatology (Oxford)"},{"key":"6170_CR7","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O\u2019Hanlon TP et al (2006) A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 54:3682\u20133689","journal-title":"Arthritis Rheum"},{"key":"6170_CR8","doi-asserted-by":"publisher","first-page":"S518","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff IN, Trieu EP, Levy-Neto M, Prasertsuntarasai T, Miller FW (2006) Autoantibodies to transcription at intermediary factor 1-gamma (TIF1-g) in dermatomyositis. Arthritis Rheum 54:S518","journal-title":"Arthritis Rheum"},{"key":"6170_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","volume":"9","author":"S Zampieri","year":"2010","unstructured":"Zampieri S, Valente M, Adami N, Biral D, Ghirardello A, Rampudda ME et al (2010) Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev 9:449\u2013453","journal-title":"Autoimmun Rev"},{"key":"6170_CR10","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/ard.2006.068502","volume":"66","author":"H Chinoy","year":"2007","unstructured":"Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG (2007) The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 66:1345\u20131349","journal-title":"Ann Rheum Dis"},{"key":"6170_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","volume":"89","author":"E Trallero-Araguas","year":"2010","unstructured":"Trallero-Araguas E, Labrador-Horrillo M, Selva-O\u2019Callaghan A, Martinez MA, Martinez-Gomez X, Palou E et al (2010) Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore) 89:47\u201352","journal-title":"Medicine (Baltimore)"},{"key":"6170_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","volume":"87","author":"A Hida","year":"2016","unstructured":"Hida A, Yamashita T, Hosono Y, Inoue M, Kaida K, Kadoya M et al (2016) Anti-TIF1-gamma antibody and cancer-associated myositis: a clinicohistopathologic study. Neurology 87:299\u2013308","journal-title":"Neurology"},{"key":"6170_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M et al (2012) Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 64:513\u2013522","journal-title":"Arthritis Rheum"},{"key":"6170_CR14","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","volume":"49","author":"K Hoshino","year":"2010","unstructured":"Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T (2010) Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology (Oxford) 49:1726\u20131733","journal-title":"Rheumatology (Oxford)"},{"key":"6170_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","volume":"72","author":"DF Fiorentino","year":"2015","unstructured":"Fiorentino DF, Kuo K, Chung L, Zaba L, Li S, Casciola-Rosen L (2015) Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1gamma antibodies in adults with dermatomyositis. J Am Acad Dermatol 72:449\u2013455","journal-title":"J Am Acad Dermatol"},{"key":"6170_CR16","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/bjd.12564","volume":"169","author":"J Wang","year":"2013","unstructured":"Wang J, Guo G, Chen G, Wu B, Lu L, Bao L (2013) Meta-analysis of the association of dermatomyositis and polymyositis with cancer. Br J Dermatol 169:838\u2013847","journal-title":"Br J Dermatol"},{"key":"6170_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"6170_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"6170_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0190-9622(91)70153-S","volume":"24","author":"RL Euwer","year":"1991","unstructured":"Euwer RL, Sontheimer RD (1991) Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol 24:959\u2013966","journal-title":"J Am Acad Dermatol"},{"key":"6170_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"key":"6170_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K et al (2007) Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) 46:25\u201328","journal-title":"Rheumatology (Oxford)"},{"key":"6170_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","volume":"45","author":"GC Dobloug","year":"2015","unstructured":"Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg O (2015) Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort. Semin Arthritis Rheum 45:301\u2013308","journal-title":"Semin Arthritis Rheum"},{"key":"6170_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/key357","volume":"58","author":"A Oldroyd","year":"2019","unstructured":"Oldroyd A, Sergeant JC, New P, McHugh NJ, Betteridge Z, Lamb JA et al (2019) The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis. Rheumatology (Oxford) 58:650\u2013655","journal-title":"Rheumatology (Oxford)"},{"key":"6170_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/art.33379","volume":"64","author":"E Trallero-Araguas","year":"2012","unstructured":"Trallero-Araguas E, Rodrigo-Pendas JA, Selva-O\u2019Callaghan A, Martinez-Gomez X, Bosch X, Labrador-Horrillo M et al (2012) Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 64:523\u2013532","journal-title":"Arthritis Rheum"},{"key":"6170_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archderm.138.7.885","volume":"138","author":"A Sparsa","year":"2002","unstructured":"Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P et al (2002) Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol 138:885\u2013890","journal-title":"Arch Dermatol"},{"key":"6170_CR26","doi-asserted-by":"crossref","unstructured":"Maoz CR, Langevitz P, Livneh A, Blumstein Z, Sadeh M, Gur H, et al., editors (1998) High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum Elsevier","DOI":"10.1016\/S0049-0172(98)80052-8"},{"key":"6170_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/ced.13180","volume":"42","author":"B Scholtissek","year":"2017","unstructured":"Scholtissek B, Ferring-Schmitt S, Maier J, Wenzel J (2017) Expression of the autoantigen TRIM 33\/TIF 1\u03b3 in skin and muscle of patients with dermatomyositis is upregulated, together with markers of cellular stress. Clin Exp Dermatol 42:659\u2013662","journal-title":"Clin Exp Dermatol"},{"key":"6170_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E et al (2005) Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 201:591\u2013601","journal-title":"J Exp Med"},{"key":"6170_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/art.38863","volume":"67","author":"P Mohassel","year":"2015","unstructured":"Mohassel P, Rosen P, Casciola-Rosen L, Pak K, Mammen AL (2015) Expression of the dermatomyositis autoantigen transcription intermediary factor 1gamma in regenerating muscle. Arthritis Rheumatol 67:266\u2013272","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06170-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T13:35:02Z","timestamp":1657892102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06170-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6170"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06170-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"assertion":[{"value":"21 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}